High-cost generic drugs--implications for patients and policymakers.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25390739.
- Also identified by DOI 10.1056/NEJMp1408376.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Some older generic drugs have become very expensive, owing to factors including drug shortages, supply disruptions, and consolidations in the generic-drug industry. But generics manufacturers that legally obtain a market monopoly can also unilaterally raise prices.
Medical subject headings
- Albendazole
- Antiparasitic Agents
- Antitrust Laws
- Drug Costs
- Drug Industry
- Drugs, Generic